STORY FROM: Talcum Powder Litigation Report
J&J Files Brief, Requests Oral Argument in Appeal of $110 Million Talc Ovarian Cancer Verdict
June 6, 2019
ST. LOUIS –– Johnson & Johnson and Johnson & Johnson Consumer Inc. have filed their brief in their appeal of a $110 million verdict in a talcum powder ovarian cancer case, asserting a number of assignments of error, including a lower court decision rejecting personal jurisdiction challenges.
On June 3, the defendants also asked the Missouri Eastern District Court of Appeals for oral argument in the matter.
In the brief, the defendants argued that the plaintiff purchased and used the products, and developed cancer, in Virginia and that their contacts with Missouri “are not constant and pervasive so as ...